Admission to study programmes at the Jagiellonian University is conducted electronically in the Online Application System: irk.uj.edu.pl. If you have any questions related to admission, please contact the Admissions Office directly or visit the websites: welcome.uj.edu.pl and irk.uj.edu.pl.
Detailed information about admission to this study programme, including information on the method of calculating the result, qualification criteria, fees, deadlines, and a list of required documents are available on the Online Application System (IRK): irk.uj.edu.pl
Programme description
Drug Discovery and Development (DDD) is a programme focused on all aspects of identifying and introducing new medicines. Its mission is to educate high-level specialists, equipped with a strong scientific basis for discovery and development of novel pharmacotherapeutics, combined with focused, real-life practical skills. This degree provides a solid grounding in pharmaceutical sciences together with an opportunity to specialise in a particular drug discovery and development area. The first semester is devoted to providing a basic understanding of drug discovery and development process as well as assuring a common level of life-sciences knowledge for candidates of various backgrounds. The second semester provides a broad and well-balanced training in pharmaceutical sciences, which serves as a basis for further specialised skills development. The third and fourth semesters are focused on one of six specialisations: Medicinal Chemistry, Molecular Pharmacology, In Vivo Pharmacology and Toxicology, Model Based Drug Development, Biological Drug Development or Generic Drug Product Development.
Graduate profile
Graduates of DDD will learn how new medicines are sought, identified, developed, manufactured and tested, along with the most important aspects of regulatory processes, necessary for their formal approval as drug products. Additionally, they will be equipped with management skills and language expertise supporting their future employment in the worldwide pharma-biotech industry, regulatory agencies or drug research centers.